This guide covers all the logo design rules, best practices, tips, examples, and more to equip you with the knowledge for crafting brilliant logos. Logos are one of the most vital elements of any ...

The funding was supposed to last for at least several more months, said Jace Flatt, an associate professor of health and behavioral sciences at the University of Nevada, Las Vegas. But on Friday ...

PORTLAND (WGME) – A proposed pause in funding for the National Institutes of Health (NIH) has sparked concerns among Maine researchers and families who rely on life-saving medical advancements.

In mid-February, I decided to leave a job I had loved as a science writer at the NIH, in large part because it seemed as if I would no longer be able to do the parts of my job that had once felt ...

She said her work involves understanding chronic and infectious diseases, and that the work done by her and her colleagues generates medical advances that keep people healthier. "I rely on NIH ...

Noscitura a sociis (nos-ə-tər ay soh-shee-is) is Latin for: “it is known by its associates.” This phrase is most often used in the context of interpreting the meaning of words in a statute, but ...

“Over the last few years, top NIH officials oversaw a culture of coverup, obfuscation, and a lack of tolerance for ideas that differed from theirs,” Bhattacharya said in prepared remarks seen ...

Researchers assessed 3,047 clinical trials that were initiated with industry funding and 1,480 clinical trials initiated with NIH funding from 2015 through 2020.

He came to the NIH in 1993 to lead the Human Genome Project, which in 2003 completed mapping the human DNA instruction book — two years ahead of schedule and $400 million under budget ...

Collins, who notified the NIH on Friday of his decision ... the long-time head of the National Institute of Allergy and Infectious Diseases, were bitterly criticized by some members of Congress ...

Fauci, a longtime colleague of Dr. Collins’s who retired at the end of 2022 as director of the National Institute of Allergy and Infectious Diseases ... leader to move @NIH forward.” ...

Cenerimod is a novel oral S1P 1 receptor modulator with potential to be a first- or best-in-class therapy for multiple autoimmune diseases Viatris previously acquired rights to cenerimod in all ...